However, this is not true for other factors such as tumor grade; moreover, there was no difference between luminal HER2-low and TNBC HER2-low (p = 0.36) and thus no impact of hormonal receptor in the HER2-low group. This evidence concerns the gene ERBB2 and neoplasm.